24Jul/13

Genentech's Obinutuzumab (GA101) Delayed Disease Progression Longer … – Wall Street Journal

Genentech’s Obinutuzumab (GA101) Delayed Disease Progression Longer
Wall Street Journal
monitoring committee determined that the study met its primary endpoint showing that GA101 plus chlorambucil helped people live significantly longer without their disease worsening (progression-free survival; PFS) compared to Rituxan(R) (rituximab

24Jul/13

NHS Reveals Plan to Increase Organ Donation to 25% by 2020 – TopNews Arab Emirates


TopNews Arab Emirates

NHS Reveals Plan to Increase Organ Donation to 25% by 2020
TopNews Arab Emirates
The plans are good news for people, who are in waiting list for organ donation. It is learnt at present the families of deceased have a final say whether they want to donate organs or not. Family’s opinion is considered important even if deceased
New organ donor memorial at Airedale HospitalIlkley Gazette
Letter from Sen. Harsdorf: Saving lives through organ donationPierce County Herald
Local boy celebrates 10-year anniversary of organ transplantFox 59
Newbury Weekly News Group –Redditch Standard
all 12 news articles »